81 FR 68437 - National Heart, Lung, and Blood Institute; Notice of Closed Meeting
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health Federal Register Volume 81, Issue 192 (October 4, 2016)
National Institutes of Health
Federal Register Volume 81, Issue 192 (October 4, 2016)
| Page Range | 68437-68437 | |
| FR Document | 2016-23881 |
[Federal Register Volume 81, Number 192 (Tuesday, October 4, 2016)] [Notices] [Page 68437] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2016-23881] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Heart, Lung, and Blood Institute; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Heart, Lung, and Blood Initial Review Group; NHLBI Mentored Patient-Oriented Research Review Committee October 27-28, 2016. Date: October 27-28, 2016. Time: 8:30 a.m. to 12:00 p.m. Agenda: To review and evaluate grant applications. Place: Cambria Suites--Rockville 1 Helen Heneghan Way, Rockville, MD 20850. Contact Person: Stephanie Johnson Webb, Ph.D., Scientific Review Officer, Office of Scientific Review/DERA, National Heart, Lung, and Blood Institute, 6701 Rockledge Drive, Room 7196, Bethesda, MD 20892, 301-435-0291, [email protected]. (Catalogue of Federal Domestic Assistance Program Nos. 93.233, National Center for Sleep Disorders Research; 93.837, Heart and Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, Blood Diseases and Resources Research, National Institutes of Health, HHS) Dated: September 28, 2016. Michelle Trout, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2016-23881 Filed 10-3-16; 8:45 am] BILLING CODE 4140-01-P
![Federal Register / Vol. 81, No. 192 / Tuesday, October 4, 2016 / Notices 68437
and communication that can facilitate addresses, as of the date this document www.fda.gov/MedicalDevices/
practical adoption of semantically publishes in the Federal Register, but NewsEvents/WorkshopsConferences/
interoperable data. Following the Web sites are subject to change over default.htm. (Select this public
presentations on each topic, there will time. workshop from the posted events list).
be a moderated discussion where the Requests for Oral Presentations: This
public workshop includes a public Dated: September 28, 2016.
participants and additional panelists
will be asked to provide their individual comment session. During online Leslie Kux,
perspectives. registration you may indicate if you Associate Commissioner for Policy.
In advance of the meeting, CDC, FDA, wish to present during a public [FR Doc. 2016–23894 Filed 10–3–16; 8:45 am]
NLM, ONC, and CMS will place an comment session, and which topics you BILLING CODE 4164–01–P
agenda on file in the public docket (the wish to address. FDA has included
docket number found in brackets in the general topics in this document. FDA
heading of this document) and will post will do its best to accommodate requests DEPARTMENT OF HEALTH AND
it at http://www.fda.gov/ to make public comments. Individuals HUMAN SERVICES
MedicalDevices/NewsEvents/ and organizations with common
WorkshopsConferences/default.htm. See interests are urged to consolidate or National Institutes of Health
DATES for the deadline for submitting coordinate their presentations, and
comments to the agenda for the public request time for a joint presentation, or National Heart, Lung, and Blood
workshop. submit requests for designated Institute; Notice of Closed Meeting
The agencies will use the input from representatives to participate in the
this workshop and public comments to public comment session. Following the Pursuant to section 10(d) of the
determine the appropriate next steps to close of registration, FDA will Federal Advisory Committee Act, as
advance semantic interoperability of determine the amount of time allotted to amended (5 U.S.C. App.), notice is
laboratory data. each presenter and the approximate hereby given of the following meeting.
Registration: Registration is free and time each oral presentation is to begin,
available on a first-come, first-served and will select and notify participants The meeting will be closed to the
basis. Persons interested in attending by November 1, 2016. All requests to public in accordance with the
this public workshop must register make oral presentations must be provisions set forth in sections
online by 4 p.m. (EDT) October 28, received by the close of registration on 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
2016. Early registration is recommended 4 p.m. (EDT) October 28, 2016. If as amended. The grant applications and
because facilities are limited and, selected for presentation, any the discussions could disclose
therefore, FDA may limit the number of presentation materials must be emailed confidential trade secrets or commercial
participants from each organization. If to Michael Waters (see FOR FURTHER property such as patentable material,
time and space permits, onsite INFORMATION CONTACT) no later than and personal information concerning
registration on the day of the public October 28, 2016. No commercial or individuals associated with the grant
workshop will be provided beginning at promotional material will be permitted applications, the disclosure of which
7 a.m. (EDT). to be presented or distributed at the would constitute a clearly unwarranted
If you need special accommodations public workshop. invasion of personal privacy.
due to a disability, please contact CDC, FDA, NLM, ONC, and CMS are
Rebecca Goodwin at 301–496–4441 holding this public workshop to obtain Name of Committee: Heart, Lung, and
(Rebecca.Goodwin@nih.gov) and/or the input from stakeholders regarding Blood Initial Review Group; NHLBI
Federal Relay at 1–800–877–8339. proposed approaches to facilitate the Mentored Patient-Oriented Research Review
Requests should be made no later than Committee October 27–28, 2016.
adoption and implementation of
November 3, 2016. Date: October 27–28, 2016.
interoperability standards in a manner
To register for the public workshop, Time: 8:30 a.m. to 12:00 p.m.
that enables consistent, accurate, and
please visit FDA’s Medical Devices Agenda: To review and evaluate grant
harmonized electronic laboratory
News & Events—Workshops & applications.
reporting. In order to permit the widest
Conferences calendar at http:// Place: Cambria Suites—Rockville 1 Helen
possible opportunity to obtain public
www.fda.gov/MedicalDevices/ Heneghan Way, Rockville, MD 20850.
comment, FDA is soliciting either
NewsEvents/WorkshopsConferences/ Contact Person: Stephanie Johnson Webb,
electronic or written comments on all
Ph.D., Scientific Review Officer, Office of
default.htm. (Select this public aspects of the public workshop topics.
Scientific Review/DERA, National Heart,
workshop from the posted events list.) See DATES for the deadline for
Lung, and Blood Institute, 6701 Rockledge
Please provide complete contact submitting comments to the agenda for
Drive, Room 7196, Bethesda, MD 20892, 301–
information for each attendee, including the public workshop.
435–0291, stephanie.webb@nih.gov.
name, title, affiliation, email, and Transcripts: Please be advised that as
telephone number. Those without soon as a transcript is available, it will (Catalogue of Federal Domestic Assistance
Internet access should contact Michael be accessible at http:// Program Nos. 93.233, National Center for
Waters to register (see FOR FURTHER www.regulations.gov. It may be viewed Sleep Disorders Research; 93.837, Heart and
INFORMATION CONTACT). Registrants will at the Division of Dockets Management Vascular Diseases Research; 93.838, Lung
receive confirmation after they have (see ADDRESSES). A transcript will also Diseases Research; 93.839, Blood Diseases
be available in either hardcopy or on and Resources Research, National Institutes
been accepted. You will be notified if
CD–ROM, after submission of a of Health, HHS)
you are on a waiting list.
mstockstill on DSK3G9T082PROD with NOTICES
Streaming Webcast of the Public Freedom of Information request. The Dated: September 28, 2016.
Workshop: This public workshop will Freedom of Information office address is
also be videocast. Videocast access will available on the Agency’s Web site at Michelle Trout,
be available at https://videocast.nih.gov/ http://www.fda.gov. A link to the Program Analyst, Office of Federal Advisory
. The videocast link will also be transcript will also be available Committee Policy.
available on the registration Web page. approximately 45 days after the public [FR Doc. 2016–23881 Filed 10–3–16; 8:45 am]
FDA has verified the Web site workshop on the Internet at http:// BILLING CODE 4140–01–P
VerDate Sep<11>2014 19:01 Oct 03, 2016 Jkt 241001 PO 00000 Frm 00040 Fmt 4703 Sfmt 9990 E:\FR\FM\04OCN1.SGM 04OCN1](https://thefederalregister.org/doc/81_FR_68629/page/1.svg)
Document Created: 2016-10-04 03:03:22
Document Modified: 2016-10-04 03:03:22
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Dates | October 27-28, 2016. | |
| FR Citation | 81 FR 68437 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR